Moxieye Gel

Introduction

Moxieye eyeGel is a prescription eye gel that contains the active ingredient Moxifloxacin. It is available under the brand name Moxieye. This medication is primarily used for the treatment of bacterial eye infections.

Uses

Moxieye eyeGel is prescribed to treat various bacterial eye infections, including conjunctivitis (pink eye) and corneal ulcers. It works by inhibiting the growth of bacteria in the eyes, helping to reduce inflammation and relieve symptoms associated with these infections.

Dosage and Administration

The recommended dosage of Moxieye eyeGel is typically one drop applied to the affected eye(s) every 4 to 8 hours, depending on the severity of the infection. Follow the instructions provided by your healthcare professional. Before applying the eye gel, wash your hands thoroughly. Tilt your head back, pull down your lower eyelid to create a small pocket, and gently squeeze the gel into the pocket. Close your eyes gently for a few moments to allow the gel to spread evenly over the surface of the eye.

Mechanism of Action

Moxifloxacin, the active ingredient in Moxieye eyeGel, belongs to a class of medications called fluoroquinolone antibiotics. It works by inhibiting the activity of enzymes that are essential for the replication and survival of bacteria. By targeting these enzymes, Moxifloxacin effectively kills or inhibits the growth of bacteria in the eyes, helping to clear up the infection.

Side Effects

Common side effects may include eye irritation, burning or stinging sensation, dryness, and blurred vision. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as severe eye pain, swelling, or changes in vision, you should seek medical attention immediately.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including prescription and over-the-counter medications, as well as any herbal supplements. Moxifloxacin, the active ingredient in Moxieye eyeGel, may interact with certain medications, such as other antibiotics or eye drops. These interactions can affect the effectiveness of the medication or increase the risk of side effects. It is best to consult with your healthcare professional to ensure the safe use of Moxieye eyeGel.

Precautions

Before using Moxieye eyeGel, inform your healthcare professional about any known allergies to medications, especially fluoroquinolone antibiotics. If you have a history of tendon problems, such as tendonitis or tendon rupture, discuss this with your healthcare professional, as fluoroquinolone antibiotics may increase the risk of these conditions. Additionally, avoid wearing contact lenses while using Moxieye eyeGel, as it may cause discoloration of the lenses.

Storage

Patient Tips

• Follow the dosage instructions provided by your healthcare professional and complete the full course of treatment, even if your symptoms improve.
• Avoid touching the tip of the applicator to any surface to prevent contamination.
• If you are using other eye drops or medications, wait at least 5 minutes between each application to allow enough time for the previous medication to be absorbed.
• If you experience any discomfort or worsening of symptoms while using Moxieye eyeGel, contact your healthcare professional.
• If you wear contact lenses, remove them before using the eye gel and wait at least 15 minutes before reinserting them.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Avelox 400 mg film-coated tablets (Health Professionals SmPC) Available at:
• Moxifloxacin oral/injection (Drugs.com) [Accessed 14 Jun. 2024] (online) Available at:
• moxifloxacin drops (RX) [Accessed 10 Jun. 2024] (online) Available at:
• Moxifloxacin (MedlinePlus) [Accessed 6 Jun. 2024] (online) Available at:
• Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, Engle M, Goldberg SV, Phan HTT, Hakim J, Johnson JL, Lourens M, Martinson NA, Muzanyi G, Narunsky K, Nerette S, Nguyen NV, Pham TH, Pierre S, Purfield AE, Samaneka W, Savic RM, Sanne I, Scott NA, Shenje J, Sizemore E, Vernon A, Waja Z, Weiner M, Swindells S, Chaisson RE; AIDS Clinical Trials Group; Tuberculosis Trials Consortium. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 May 6;384(18):1705-1718. doi: 10.1056/NEJMoa2033400. [Accessed 12 Jun. 2024] Available at: